Dr. Bana Jabri, NFCA Medical and Scientific Advisory Board member, leads University of Chicago team in groundbreaking mouse model research.
The University of Chicago Celiac Disease Center recently received a multi-million dollar commitment to launch the first-ever mouse model for celiac disease. This landmark mouse model project promises to help researchers identify the underlying causes of celiac disease and test new therapies.
These mouse model studies may also reveal specific triggers leading to the development of Type 1 diabetes in children and adults.
Dr. Bana Jabri, Associate Professor at the University of Chicago, leads the team developing the first mouse model dedicated to celiac disease. Dr. Jabri also serves as a program advisor on NFCA’s Scientific/Medical Advisory Board.
“When I read the press release, I felt like my heart was going burst wide open,” says NFCA President Alice Bast. “ Having known about Dr. Jabri’s mouse model since we were first introduced four years ago, it’s thrilling to hear that this critically important project has finally secured the funding to launch.”
“This mouse model will give us a greater understanding of celiac disease than ever before, and yield discoveries and information about a host of other autoimmune disorders as well,.” adds Bast.
To learn more about the first ever mouse-model for celiac disease, read the Friday, May 29,2009 press release issued by the University of Chicago.